A Randomized, Placebo-Controlled, Parallel Treatment Group, Double-Masked Study to Evaluate the Efficacy and Safety of Three Doses of Oral Optina(TM) in Adult Subjects with Diabetic Macular Edema

Trial Profile

A Randomized, Placebo-Controlled, Parallel Treatment Group, Double-Masked Study to Evaluate the Efficacy and Safety of Three Doses of Oral Optina(TM) in Adult Subjects with Diabetic Macular Edema

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Jul 2012

At a glance

  • Drugs Danazol (Primary)
  • Indications Diabetic macular oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jul 2012 Secondary endpoint 'Best-corrected-visual-acuity' has been met, according to an Ampio Pharmaceuticals media release.
    • 09 Jul 2012 Primary endpoint 'Central-retinal-thickness' has been met, according to an Ampio Pharmaceuticals media release.
    • 27 Apr 2012 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top